COVID-19 Seroprevalence and Active Infection in an Asymptomatic Population

COVID-19 Seroprevalence and Active Infection in an Asymptomatic Population

In response to the COVID-19 pandemic, immediate and scalable testing solutions are needed to direct return to full capacity planning in the general public and across the Department of Defense (DoD). To fully understand the extent to which a population has been affected by COVID-19, active monitoring...

Full description

Bibliographic Details
Main Authors: Amy M. E. Breedon, Roland J. Saldanha, Richard L. Salisbury, David E. Metzger, Michael P. Werry, Craig J. McPherson, Adam P. Irvin, Christina M. Davis, Charles A. Bogner, Amber M. Braddock, Charles E. Salter, Claude C. Grigsby, Corey R. Hart, Heather A. Pangburn
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
COVID-19
SARS-CoV-2
saliva
testing
seroprevalance
antibodies
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.749732/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.749732/full

Similar Items